Table 2.

Clinical and critical immune cell composition (identified via XAI) from bulk RNA-seq data of TNBC patients that survived for less than 5 years.

TCGA Patient ID	Stage	Age	Months	B Cell	M0 Macrophage	CD8+ T Cell	NK T Cell
A1-A0SK	II	54	31.8	0.003	0.325	0.000	0.000
A2-A0CM	II	40	24.8	0.008	0.129	0.025	0.013
A2-A0T2	IV	66	8.4	0.001	0.077	0.098	0.183
A2-A3XY	II	49	35.9	0.013	0.261	0.049	0.072
AC-A2QJ	III	48	14.7	0.000	0.196	0.000	0.146
AR-A5QQ	III	68	10.6	0.017	0.109	0.259	0.061
B6-A3ZX	IV	50	37.9	0.145	0.058	0.110	0.058
B6-A409	III	44	18.8	0.002	0.052	0.000	0.096
BH-A1EW	II	38	55.7	0.004	0.000	0.244	0.047
C8-A3M7	III	60	34.0	0.008	0.000	0.216	0.014
E2-A1LK	III	84	8.7	0.005	0.650	0.000	0.034
EW-A1P8	III	58	7.9	0.003	0.000	0.034	0.101